中国执业药师2016，Vol.13Issue(4)：38-42,5.DOI:10.3969/j.issn.1672-5433.2016.04.008
低分子肝素诱导的血小板减少症患者的用药分析
Drug Use in Patients with Thrombocytopenia Induced by Low Molecular Weight (LMW) Heparin
摘要
Abstract
The diagnosis,substitute anticoagulant therapy and key points of pharmaceutical care were investigat-ed by analysis of one case of thrombocytopenia induced by low molecular weight (LMW) heparin after percuta-neous coronary intervention.关键词
低分子肝素/血小板减少症/替代抗凝治疗/比伐卢定/药学监护Key words
Low-molecular-weight Heparin/Thrombocytopenia/Substitute Anticoagulant Therapy/Bivalirudin/Pharmaceutical Care引用本文复制引用
荣春蕾,管鸽,陈玉善,邱承杰..低分子肝素诱导的血小板减少症患者的用药分析[J].中国执业药师,2016,13(4):38-42,5.基金项目
江苏省常州四药临床药学基金 （）
